BLFS - BioLife Solutions, Inc.
10.21 -0.24 (-2.32%)
After hours: 4:11PM EST
| Previous Close | 10.03 |
| Open | 9.76 |
| Bid | 10.01 x 800 |
| Ask | 10.65 x 800 |
| Day's Range | 9.67 - 10.57 |
| 52 Week Range | 4.63 - 26.35 |
| Volume | 110,550 |
| Avg. Volume | 289,107 |
| Market Cap | 193.323M |
| Beta (3Y Monthly) | 3.04 |
| PE Ratio (TTM) | 135.71 |
| EPS (TTM) | 0.08 |
| Earnings Date | Nov 7, 2018 - Nov 12, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.00 |
- Thomson Reuters StreetEvents•5 hours ago
Edited Transcript of BLFS earnings conference call or presentation 8-Nov-18 9:30pm GMT
Q3 2018 Biolife Solutions Inc Earnings Call
- PR Newswire•8 days ago
BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences
BOTHELL, Wash. , Nov. 13, 2018 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary biopreservation media products ...
- PR Newswire•12 days ago
BioLife Solutions Announces Third Quarter 2018 Financial Results
Revenue increases 79% to a record $5.3 million ; achieves net income of $1.2 million Conference call and webcast begin at 4:30 p.m. Eastern time today BOTHELL, Wash. , Nov. 8, 2018 /PRNewswire/ -- BioLife ...
- Zacks•16 days ago
BioLife (BLFS) to Report Q3 Earnings: What's in the Cards?
BioLife (BLFS) is likely to gain from solid segmental revenues in Q3.
- PR Newswire•16 days ago
SAVSU Technologies to Supply evo® Cold Chain Technologies to AveXis
Temperature Sensitive Gene Therapy Protected by Cloud-Connected Smart Shipper and evo.is Cloud App for Real Time Distribution Visibility and Management ALBUQUERQUE, N.M. , Nov. 5, 2018 /PRNewswire/ -- SAVSU ...
- PR Newswire•20 days ago
BioLife Solutions to Report Third Quarter 2018 Financial Results and Provide Business Update on November 8, 2018
BOTHELL, Wash. , Nov. 1, 2018 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media, ("BioLife" ...
- GlobeNewswire•last month
Market Trends Toward New Normal in Rambus, GMS, Advanced Energy Industries, AZZ, BioLife Solutions, and Spartan Motors — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Oct. 18, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Zacks•2 months ago
BioLife Solutions Sees Hammer Chart Pattern: Time to Buy?
BioLife Solutions has been struggling lately, but the selling pressure may be coming to an end soon.
- PR Newswire•2 months ago
BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year
BOTHELL, Wash., Oct. 1, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, today reported preliminary revenue for the three months ended September 30, 2018 and provided updated revenue guidance for the full year of 2018. Third quarter 2018 preliminary revenue from sales of BioLife's biopreservation media products reached a record $5.3 million, representing a 79% increase over the third quarter of 2017. BioLife CEO Mike Rice commented, "Strong product demand continued in the third quarter of 2018, with sustained growth from our two most strategic revenue segments.
- Zacks•2 months ago
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?
Is (BLFS) Outperforming Other Medical Stocks This Year?
Market Realist•2 months agoBioLife Solutions: On a Strong Footing
BioLife Solutions (BLFS) develops, manufactures, and commercializes cell and tissue hypothermic storage and cryopreservation freeze media. BioLife Solutions generated revenues of $5.18 million in the second quarter compared to $2.56 million in the second quarter of 2017. For fiscal 2018 and fiscal 2019, BioLife is expected to generate revenues of $19.89 million and $28.36 million, respectively, compared to $11.02 million in fiscal 2017.
Market Realist•2 months agoAnalysts Still Bullish about BioLife Solutions
BioLife Solutions (BLFS) generated a net income of $1.05 million in the second quarter compared to a net loss of $768,212 in the second quarter of 2017. That translates to net income per share of $0.05 in the second quarter. Its net loss per share was $0.06 in the second quarter of 2017.
Market Realist•2 months agoAudentes Therapeutics’ Promising Product Pipeline
Gene therapy involves repairing or replacing disease-causing genes. Investor interest in gene therapy stocks has remained buoyant throughout 2018. According to Allied Market Research, the gene therapy market is expected to grow at a 33.3% CAGR (compound annual growth rate) to $4.4 billion by 2023.
- PR Newswire•3 months ago
BioLife Solutions Increases Ownership in SAVSU Technologies to 44% with $5 Million Investment
BOTHELL, Wash., Sept. 5, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading supplier of proprietary biopreservation media products for cell and gene therapies, today announced that it has increased its ownership of SAVSU Technologies from approximately 31% to 44% with a $5 million investment. SAVSU will use the investment to scale up its operations and inventory to support increased demand for its evo® Dry Vapor Shippers and other precision temperature controlled shipping containers for cell and gene therapies. The 18-month purchase option provides BioLife, at its sole discretion, with the right to acquire the 56% of SAVSU not already owned, for the greater of 1,000,000 shares of BioLife common stock, or approximately $23 million of BioLife common stock, calculated on the day of exercise. If BioLife exercises the purchase option in the future, 75% of the shares would be issued at closing, with the remaining 25% issued upon the achievement of specific revenue milestones.
- Zacks•3 months ago
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
- Zacks•3 months ago
Trump's Approval Rating Buoy Wall Street: 4 Top Gainers
Trump's pro-growth agenda has worked wonders for the economy as a whole.
- Zacks•3 months ago
Canopy Growth (CGC) Jumps: Stock Rises 7.4%
Canopy Growth (CGC) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
- Zacks•3 months ago
Bull Run to Continue in Rest of 2018: 5 Terrific Growth Picks
Strong economic fundamentals of the United States suggest that the recent volatility may be transitory and that markets will continue their uptrend.
- GlobeNewswire•3 months ago
Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel — New Research Emphasizes Economic Growth
NEW YORK, Aug. 24, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Seres ...
- Zacks•3 months ago
Medtronic (MDT) Surges: Stock Moves 5.7% Higher
Medtronic (MDT) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
- PR Newswire•3 months ago
BioLife Solutions to Ring NASDAQ Closing Bell on August 29, 2018
BOTHELL, Wash. , Aug. 22, 2018 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife"), the leading supplier of proprietary biopreservation media products for cell and gene therapies ...
- Zacks•3 months ago
PetIQ (PETQ) Catches Eye: Stock Jumps 9.1%
PetIQ (PETQ) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of BLFS earnings conference call or presentation 9-Aug-18 2:00pm GMT
Q2 2018 BioLife Solutions Inc Earnings Call
- PR Newswire•3 months ago
BioLife Solutions Announces Second Quarter 2018 Financial Results
Revenue increases 102% to $5.2 million . Net income of $1.0 million achieved Full-year 2018 GAAP net income expected Conference call and webcast begin at 10:00 a.m. Eastern time today BOTHELL, Wash. , ...
